Related Experiment Videos
What is new in endocrine therapy of prostatic cancer?
1Department of Urology, Erasmus University and Academic Hospital, Rotterdam, The Netherlands.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data.
Journal of the National Cancer Institute·2014
Blinded and uniform causes of death verification in cancer screening: a major influence on the outcome of a prostate cancer screening trial?
European journal of cancer (Oxford, England : 1990)·2010
Prostate cancer: trends in incidence, survival and mortality in the Netherlands, 1989-2006.
European journal of cancer (Oxford, England : 1990)·2010
DNA homology and chromosome stability: a sensitive yeast genetic system for identifying double-stranded DNA damage.
Progress in clinical and biological research·2018
Interaction of lipopolysaccharide with a mammalian lyso-phosphatidate acyltransferase (LPAAT) transfected into E. coli, and effect of lisofylline on LPAAT transfected into mammalian cells.
Progress in clinical and biological research·1998
The molecular basis for therapeutic concepts utilizing CD14.
Progress in clinical and biological research·1998
Endotoxin tolerance alters macrophage membrane regulatory G proteins.
Progress in clinical and biological research·1998
Molecular mechanisms responsible for endotoxin tolerance.
Progress in clinical and biological research·1998
Antibiotic-mediated release of endotoxin and the pathogenesis of gram-negative sepsis.
Progress in clinical and biological research·1998
Radium-223 decreases PD-L1 expression in bone metastases: A study with [89Zr]Zr-atezolizumab PET and immunohistological correlation.
European journal of nuclear medicine and molecular imaging·2026
Radiopharmaceutical Combination Therapies in Advanced Prostate Cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Engineered nano-delivery platforms targeting ferroptosis-evasion pathways to reverse tumor drug resistance.
Biochimica et biophysica acta. Reviews on cancer·2026
Antibody therapeutics: A new era for EGFR-mutant NSCLC treatment.
Biochimica et biophysica acta. Reviews on cancer·2026